Christoph Lichtenstern
- Epidemiology top 5%
- Infectious Diseases top 5%
- Critical Care and Intensive Care Medicine top 1%
- Surgery
- Pharmacology top 5%
- Co-authors
- Markus A. WeigandFlorian UhleMarkus WeigandThorsten BrennerEike MartinTorsten Hoppe‐TichySebastian WeitererStefan Hofer
- Topics
- Antifungal resistance and susceptibility (23 papers)Sepsis Diagnosis and Treatment (20 papers)Antibiotics Pharmacokinetics and Efficacy (13 papers)
- Cited by
- Critical Care and Intensive Care MedicineApplied Microbiology and BiotechnologyEpidemiology
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Christoph Lichtenstern
88 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 118
- Epidemiology 698
- Infectious Diseases 290
- Critical Care and Intensive Care Medicine 275
- Surgery 265
- Pharmacology 217
Countries citing papers authored by Christoph Lichtenstern
This map shows the geographic impact of Christoph Lichtenstern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Lichtenstern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Lichtenstern more than expected).
Fields of papers citing papers by Christoph Lichtenstern
This network shows the impact of papers produced by Christoph Lichtenstern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Lichtenstern. The network helps show where Christoph Lichtenstern may publish in the future.
Co-authorship network of co-authors of Christoph Lichtenstern
This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Lichtenstern. A scholar is included among the top collaborators of Christoph Lichtenstern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Lichtenstern. Christoph Lichtenstern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 5 | |
| 7 | 6 | |
| 8 | 14 | |
| 9 | 5 | |
| 10 | 3 | |
| 11 | 5 | |
| 12 | 9 | |
| 13 | 5 | |
| 14 | 7 | |
| 15 | Patientensicherheit in der Anästhesie : Multimodale Strategien für die perioperative Versorgung. | 2 |
| 16 | Update: invasive Pilzinfektionen: Diagnose und Therapie in der operativen Intensivmedizin | 7 |
| 17 | 1 | |
| 18 | 5 | |
| 19 | 3 | |
| 20 | 6 |
About Christoph Lichtenstern
Christoph Lichtenstern is a scholar working on Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 91 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (23 papers), Sepsis Diagnosis and Treatment (20 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (275 citations), Applied Microbiology and Biotechnology (98 citations) and Epidemiology (698 citations). Christoph Lichtenstern has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Markus A. Weigand, Florian Uhle, Markus Weigand, Thorsten Brenner, Eike Martin, Torsten Hoppe‐Tichy, Sebastian Weiterer, Stefan Hofer, Markus A. Weigand and Konstantin Mayer. Their work appears in journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.